Open AccessStability of Human Serum Amyloid A Fibrils
Author(s) -
Wenhua Wang,
Ulrich H. E. Hansmann
Publication year - 2020
Publication title -
the journal of physical chemistry. b
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 392
eISSN - 1520-6106
pISSN - 1520-5207
DOI - 10.1021/acs.jpcb.0c08280
Subject(s) - fibril , tetramer , salt bridge , stacking , monomer , chemistry , biophysics , amyloid (mycology) , dimer , amyloid fibril , crystallography , molecular dynamics , nucleation , hydrogen bond , molecule , amyloid β , polymer , biochemistry , mutant , computational chemistry , organic chemistry , enzyme , medicine , inorganic chemistry , disease , pathology , biology , gene
In systemic amyloidosis, serum amyloid A (SAA) fibril deposits cause widespread damages to tissues and organs that eventually may lead to death. A therapeutically intervention therefore has either to dissolve these fibrils or inhibit their formation. However, only recently has the human SAA fibril structure been resolved at a resolution that is sufficient for development of drug candidates. Here, we use molecular dynamic simulations to probe the factors that modulate the stability of this fibril model. Our simulations suggest that fibril formation starts with the stacking of two misfolded monomers into metastable dimers, with the stacking depending on the N-terminal amyloidogenic regions of different chains forming anchors. The resulting dimers pack in a second step into a 2-fold two-layer tetramer that is stable enough to nucleate fibril formation. The stability of the initial dimers is enhanced under acidic conditions by a strong salt bridge and side-chain hydrogen bond network in the C-terminal cavity (residues 23-51) but is not affected by the presence of the disordered C-terminal tail.